BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu WB, Rao A, Vu V, Xu L, Rao JY, Wu JX. Management of centrally located hepatocellular carcinoma: Update 2016. World J Hepatol 2017; 9(13): 627-634 [PMID: 28539990 DOI: 10.4254/wjh.v9.i13.627] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Mao HX, Chen BW, Wang J, Ma CY, Gan YC, Qiu KJ. miR-3677-5p promotes the proliferation, migration and invasion of hepatocellular carcinoma cells and is associated with prognosis. Exp Ther Med 2021;22:780. [PMID: 34055079 DOI: 10.3892/etm.2021.10212] [Reference Citation Analysis]
2 Zhu S, Tan W, Li W, Zhou R, Wu X, Chen X, Li W, Shang C, Chen Y. Low expression of VSIG4 is associated with poor prognosis in hepatocellular carcinoma patients with hepatitis B infection. Cancer Manag Res. 2018;10:3697-3705. [PMID: 30288101 DOI: 10.2147/cmar.s165822] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Cao X, Zhang G, Li T, Zhou C, Bai L, Zhao J, Tursun T. LINC00657 knockdown suppresses hepatocellular carcinoma progression by sponging miR-424 to regulate PD-L1 expression. Genes Genomics 2020;42:1361-8. [PMID: 32996041 DOI: 10.1007/s13258-020-01001-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Du P, Luo K, Li G, Zhu J, Xiao Q, Li Y, Zhang X. PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis. Int J Med Sci 2021;18:3588-98. [PMID: 34522186 DOI: 10.7150/ijms.62467] [Reference Citation Analysis]
5 Zhang J, Song Q, Liu J, Lu L, Xu Y, Zheng W. Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma. Dis Markers 2019;2019:8964015. [PMID: 31781310 DOI: 10.1155/2019/8964015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Xu W, Wang X, Wu X, Yu S, Xiong J, Sang X, Zheng Y, Zhang Z. Prognostic value and underlying mechanism of KIAA0101 in hepatocellular carcinoma: database mining and co-expression analysis. Aging (Albany NY) 2020;12:16420-36. [PMID: 32855364 DOI: 10.18632/aging.103704] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Zhang Z, Yao Z, Chen Y, Qian L, Jiang S, Zhou J, Shao J, Chen A, Zhang F, Zheng S. Lipophagy and liver disease: New perspectives to better understanding and therapy. Biomed Pharmacother. 2018;97:339-348. [PMID: 29091883 DOI: 10.1016/j.biopha.2017.07.168] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
8 Carling U, Barkhatov L, Reims HM, Storås T, Courivaud F, Kazaryan AM, Halvorsen PS, Dorenberg E, Edwin B, Hol PK. Can we ablate liver lesions close to large portal and hepatic veins with MR-guided HIFU? An experimental study in a porcine model. Eur Radiol 2019;29:5013-21. [PMID: 30737565 DOI: 10.1007/s00330-018-5996-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
9 Yan X, Wu T, Tang M, Chen D, Huang M, Zhou S, Zhang H, Yang X, Li G. Methylation of the ataxia telangiectasia mutated gene (ATM) promoter as a radiotherapy outcome biomarker in patients with hepatocellular carcinoma. Medicine (Baltimore) 2020;99:e18823. [PMID: 31977876 DOI: 10.1097/MD.0000000000018823] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Wang X, Wang X, Li W, Zhang Q, Chen J, Chen T. Up-Regulation of hsa_circ_0000517 Predicts Adverse Prognosis of Hepatocellular Carcinoma. Front Oncol 2019;9:1105. [PMID: 31750237 DOI: 10.3389/fonc.2019.01105] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
11 Chen S, Yang C, Sun C, Sun Y, Yang Z, Cheng S, Zhuge B. miR-21-5p Suppressed the Sensitivity of Hepatocellular Carcinoma Cells to Cisplatin by Targeting FASLG. DNA Cell Biol 2019;38:865-73. [PMID: 31225740 DOI: 10.1089/dna.2018.4529] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
12 Li G, Li W, Li S, Shi X, Liang J, Lai J, Zhou Z. A novel aptasensor based on light-addressable potentiometric sensor for the determination of Alpha-fetoprotein. Biochemical Engineering Journal 2020;164:107780. [DOI: 10.1016/j.bej.2020.107780] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
13 Kou X, Zhu J, Xie X, Hao M, Zhao Y. Expression of lncRNA MSC-AS1 in hepatocellular carcinoma cell lines and its effect on proliferation, apoptosis, and migration. Turk J Gastroenterol 2020;31:860-7. [PMID: 33625998 DOI: 10.5152/tjg.2020.19485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wang X, Wang X, Xu Y, Yan M, Li W, Chen J, Chen T. Effect of nicastrin on hepatocellular carcinoma proliferation and apoptosis through PI3K/AKT signalling pathway modulation. Cancer Cell Int 2020;20:91. [PMID: 32226312 DOI: 10.1186/s12935-020-01172-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
15 Al-Azzawi Y, Rouanet E, Hendrix RJ, Spaho L, Malik H, Devuni D, Szabo G, Barnard G. Segmental Distribution of Hepatocellular Carcinoma Correlates with Microvascular Invasion in Liver Explants Undergoing Transplantation. J Cancer Epidemiol 2019;2019:8534372. [PMID: 31186641 DOI: 10.1155/2019/8534372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Wang L, Min Z, Wang X, Hu M, Song D, Ren Z, Cheng Y, Wang Y. Arsenic trioxide and sorafenib combination therapy for human hepatocellular carcinoma functions via up-regulation of TNF-related apoptosis-inducing ligand. Oncol Lett 2018;16:3341-50. [PMID: 30127933 DOI: 10.3892/ol.2018.8981] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Soga S, Kuwamura H, Edo H, Suyama Y, Hamabe F, Sugiura H, Einama T, Shinmoto H. Double Balloon-Occluded Transarterial Chemoembolization (Double B-TACE) for Hepatocellular Carcinomas Located in the Caudate Lobe. Cardiovasc Intervent Radiol 2020;43:162-4. [DOI: 10.1007/s00270-019-02333-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
18 Xiao Y, Li W, Wan H, Tan Y, Wu H. Central hepatectomy versus major hepatectomy for patients with centrally located hepatocellular carcinoma: A meta-analysis. Int J Surg 2018;52:297-302. [PMID: 29530828 DOI: 10.1016/j.ijsu.2018.02.059] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
19 Zhu LJ, Pan Y, Chen XY, Hou PF. BUB1 promotes proliferation of liver cancer cells by activating SMAD2 phosphorylation. Oncol Lett 2020;19:3506-12. [PMID: 32269624 DOI: 10.3892/ol.2020.11445] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
20 Huang XF, Sheu GT, Chang KF, Huang YC, Hung PH, Tsai NM. Pogostemon cablin Triggered ROS-Induced DNA Damage to Arrest Cell Cycle Progression and Induce Apoptosis on Human Hepatocellular Carcinoma In Vitro and In Vivo. Molecules 2020;25:E5639. [PMID: 33266043 DOI: 10.3390/molecules25235639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Fu Q, Yang F, Zhao J, Yang X, Xiang T, Huai G, Zhang J, Wei L, Deng S, Yang H. Bioinformatical identification of key pathways and genes in human hepatocellular carcinoma after CSN5 depletion. Cell Signal 2018;49:79-86. [PMID: 29885455 DOI: 10.1016/j.cellsig.2018.06.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
22 Rong W, Yu W, Wang L, Wu F, Zhang K, Chen B, Miao C, Liu L, An S, Tao C, Wang W, Wu J. Adjuvant radiotherapy in central hepatocellular carcinoma after narrow-margin hepatectomy: A 10-year real-world evidence. Chin J Cancer Res 2020;32:645-53. [PMID: 33223759 DOI: 10.21147/j.issn.1000-9604.2020.05.09] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Fu Q, Yang F, Xiang T, Huai G, Yang X, Wei L, Yang H, Deng S. A novel microRNA signature predicts survival in liver hepatocellular carcinoma after hepatectomy. Sci Rep 2018;8:7933. [PMID: 29785036 DOI: 10.1038/s41598-018-26374-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
24 Le Treut YP, Grégoire E, Fara R, Giuly JA, Chopinet S, Delpero J, Hardwigsen J. The technique and outcomes of central hepatectomy by the Glissonian suprahilar approach. European Journal of Surgical Oncology 2019;45:2369-74. [DOI: 10.1016/j.ejso.2019.09.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Li Y, Yang J, Zhang X, Liu H, Guo J. KDM6A suppresses hepatocellular carcinoma cell proliferation by negatively regulating the TGF-β/SMAD signaling pathway. Exp Ther Med 2020;20:2774-82. [PMID: 32765772 DOI: 10.3892/etm.2020.9000] [Reference Citation Analysis]
26 Ni Q, Chen Z, Zheng Q, Xie D, Li JJ, Cheng S, Ma X. Epithelial V-like antigen 1 promotes hepatocellular carcinoma growth and metastasis via the ERBB-PI3K-AKT pathway. Cancer Sci 2020;111:1500-13. [PMID: 31997489 DOI: 10.1111/cas.14331] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]